Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

H-Lys-OH·HCl

    • Product Name H-Lys-OH·HCl
    • Alias LYS
    • Einecs 204-873-0
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    389905

    product_name H-Lys-OH·HCl
    chemical_name L-Lysine hydrochloride
    molecular_formula C6H15ClN2O2
    molecular_weight 182.65 g/mol
    appearance White crystalline powder
    solubility_in_water Freely soluble
    melting_point 263-265°C (decomposition)
    CAS_number 657-27-2
    pH_of_1_percent_solution 5.0-6.0
    storage_conditions Store at room temperature, dry and tightly closed

    As an accredited H-Lys-OH·HCl factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing H-Lys-OH·HCl is packaged in a sealed 25g amber glass bottle, with tamper-evident cap and clear labeling for identification.
    Shipping **Shipping Description for H-Lys-OH·HCl:** Shipped in tightly sealed containers under ambient conditions. Product is stable at room temperature and not classified as hazardous for transport. Store away from strong oxidizers and moisture. Ensure proper labeling, including chemical name and hazard information per GHS guidelines. Use sturdy packaging to prevent breakage or spillage during transit.
    Storage H-Lys-OH·HCl (L-Lysine hydrochloride) should be stored in a tightly sealed container, protected from moisture and direct sunlight. Keep at 2–8°C (refrigerated) in a dry, well-ventilated area away from incompatible substances such as strong oxidizers. Ensure the storage space is clearly labeled and follow standard laboratory safety protocols to prevent contamination or degradation of the compound.
    Application of H-Lys-OH·HCl

    Applications of H-Lys-OH·HCl in Industrial Manufacturing

    We manufacture H-Lys-OH·HCl to stringent quality standards for a range of precisely controlled industrial supply chains. This section details its main industrial applications, with process details and compliance references specific to each sector.

    1. Peptide Synthesis for Pharmaceutical API Manufacturing

    H-Lys-OH·HCl is a critical protected amino acid building block for solid and liquid phase peptide synthesis (SPPS, LPPS), essential in producing pharmaceutical-grade peptide APIs such as peptide hormones, enzyme inhibitors, and diagnostic agents. Our high-purity material integrates at the elongation and deprotection steps, ensuring batch-to-batch consistency. Downstream partners depend on correct optical purity and chloride control to meet N-1 and N-2 impurity limits for regulatory filings.

    Industry compliance standards

    • ICH Q7 cGMP for Active Pharmaceutical Ingredients
    • U.S. Pharmacopeia (USP) specifications for amino acids
    • European Pharmacopoeia (Ph. Eur.) monograph 0827
    • FDA 21 CFR Part 211 – Finished Pharmaceuticals

    Typical usage ratio

    • 1.05–1.15 molar equivalents per lysine residue in solid phase protocols
    • Adjustments depend on coupling efficiency and desired yield, usually within 2-10% over theoretical stoichiometry

    Downstream process integration

    • Direct charge to resin for stepwise peptide elongation
    • Buffer exchange and desalting post-coupling
    • Integrated during side-chain deprotection prior to peptide cleavage from support

    Final product types

    • Pharmaceutical intermediate peptides (e.g., Liraglutide, Octreotide, peptide vaccines)
    • Bulk API peptides for sterile fill-and-finish
    • Synthetic diagnostic peptides for in vitro assay kits
    • Reference standards for analytical labs

    2. Food and Nutritional Supplement Ingredient Manufacturing

    Food manufacturers use H-Lys-OH·HCl as an essential source of L-lysine in the formulation of functional food fortifiers and dietary supplements. It enters at the granulation or blending stage for direct consumption or as a microencapsulation substrate. Downstream users must comply with identity and purity specs set by food safety authorities, and dosage is strictly calculated based on target protein content for human nutrition or personalized health applications.

    Industry compliance standards

    • FCC (Food Chemicals Codex) specification for L-lysine monohydrochloride
    • GB 25542–2010 China Food Additive National Standard
    • EU Regulation (EC) No 1333/2008 on food additives
    • ISO 22000 Food Safety Management System in downstream production

    Typical usage ratio

    • 0.2–0.5% by weight in protein beverages and fortified milk powders
    • Range varies based on regulatory maximums and desired amino acid profile

    Downstream process integration

    • Blending during premix formulation for nutritional powders and tablets
    • Incorporation post-spray drying for beverage applications
    • Use in controlled-release pellet production via extrusion-spheronization

    Final product types

    • Infant and adult nutritional supplements
    • Sports protein drink powder premixes
    • Tablet and capsule health foods targeting amino acid supplementation
    • Amino acid-fortified meal replacement products

    3. Cell Culture Media Formulation for Biotechnology

    Biopharma and industrial biotech sectors rely on highly purified H-Lys-OH·HCl as a key media supplement for mammalian, insect, and microbial cell culture. It supports high-density cell growth and recombinant protein expression. The material is introduced under strict aseptic conditions during media batch preparation, with trace metal and endotoxin specifications validated for cell-based production platforms.

    Industry compliance standards

    • USP General Chapter <797> for Pharmaceutical Compounding—Sterile Preparations
    • ISO 13408-1 Aseptic Processing of Healthcare Products
    • ICH Q5A/B/C for Biotechnological/Biological Product Quality
    • FDA Guidance on Media Components for Cell and Gene Therapy

    Typical usage ratio

    • 0.05–0.2 g/L in basal and feed media for industrial cell lines
    • Optimization by cell type, scaling with amino acid depletion monitoring

    Downstream process integration

    • Initial hydration with bulk media salts before sterile filtration
    • Incremental feeding during high-density fed-batch fermentation
    • Dissolution and sterile addition in single-use bioreactor systems

    Final product types

    • Therapeutic monoclonal antibodies and biosimilars
    • Recombinant protein expression systems (e.g., enzymes, cytokines)
    • Vaccine antigen production (cell-based and viral vector platforms)
    • Cell therapy media and regenerative medicine intermediates

    4. Diagnostic Reagent and Test Kit Production

    Manufacturers of in vitro diagnostic (IVD) reagents and life science research kits incorporate H-Lys-OH·HCl in the synthesis of peptide antigens, enzyme substrates, and calibration references. High purity and trace impurity control are critical, as the ingredient directly affects assay specificity and shelf-life. It enters at the raw material staging for custom substrate synthesis, often referenced in kit QC documentation for traceability in regulated environments.

    Industry compliance standards

    • ISO 13485: Medical Devices Quality Management
    • EN 13640 for Stability Testing of IVD Devices
    • CLSI GP42 for Preparation and Testing of Reagents
    • IVDR (EU Regulation 2017/746) for medical diagnostics

    Typical usage ratio

    • 100–300 mg per 1 g of diagnostic peptide, adjusted for intended assay reactivity
    • Concentration set by IVD kit formulation protocol, dependent on detection method sensitivity

    Downstream process integration

    • Raw feedstock for peptide antigen synthesis (solid-phase and solution phase)
    • Included in substrate formulations for enzyme-linked immunosorbent assays (ELISA)
    • Reference standard calibration in quantitative diagnostic systems

    Final product types

    • ELISA kits and rapid diagnostic test cassettes
    • Synthetic peptide reference standards
    • Calibration materials for clinical chemistry analyzers
    • Research-grade substrate reagent sets

    5. Veterinary Drug Ingredient Production

    Veterinary pharmaceutical producers utilize H-Lys-OH·HCl in the synthesis of peptide-based veterinary drugs, as well as amino acid supplements for animal health. Typical integration points are during active ingredient synthesis and during granulation or tablet formation for animal feed supplements. Finished products must meet national veterinary medicine quality requirements and are often subjected to residue and cross-contamination monitoring.

    Industry compliance standards

    • VICH GL18 Good Manufacturing Practices for Active Pharmaceutical Ingredients in Veterinary Medicinal Products
    • Ph. Eur. and USP Veterinary Monographs
    • China Veterinary Pharmacopoeia
    • ISO 9001 in animal health formulation

    Typical usage ratio

    • 2–8% by mass in feed premix formulations based on species dietary lysine requirement
    • 0.5–2.0 molar equivalents for synthesis of peptide-based actives

    Downstream process integration

    • Granulation with excipients for direct compression tablets and boluses
    • Addition to controlled-release pelletizers for feed supplements
    • Active coupling in synthesis of peptide veterinary API

    Final product types

    • Lysine-enriched premix for animal feed
    • Veterinary peptide pharmaceuticals (injectables, oral tablets)
    • Nutritional bolus and slow-release supplement blocks
    • Veterinary diagnostic kit raw materials

    6. Specialty Biopolymer and Material Modification

    Industrial polymer and material manufacturers leverage H-Lys-OH·HCl for bioconjugation and surface modification. It contributes reactive amine and carboxyl groups to engineered biopolymers, including surface coatings, medical-grade hydrogels, and smart biomaterials with cell-adhesion functions. Purity and salt content must align with downstream polymerization and curing requirements to prevent process inhibition and ensure consistent biocompatibility outcomes.

    Industry compliance standards

    • ISO 10993 Biocompatibility Evaluation of Medical Devices
    • USP Class VI for polymer materials in medical applications
    • REACH Regulation (EC) No 1907/2006 for chemical safety
    • FDA 21 CFR 177.2600 for indirect food contact polymers

    Typical usage ratio

    • 0.1–1.0% by mass in hydrogel precursor blends or conjugate formulations
    • Adjusted based on the intended degree of functional surface modification

    Downstream process integration

    • Co-polymerization or grafting during material synthesis
    • Pre-treatment for biomaterial coatings
    • Terminal derivatization for ligand attachment in smart material manufacturing

    Final product types

    • Hydrogel wound dressings and tissue scaffolds
    • Cell culture ware with bioactive surface modification
    • Biopolymer-based medical device components
    • Enzyme-immobilized nanomaterials and biosensor substrates
    Free Quote

    Competitive H-Lys-OH·HCl prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    H-Lys-OH·HCl: Reliable L-Lysine Hydrochloride Direct From the Factory Floor

    The Backbone of Specialized Peptide Manufacturing

    Working with H-Lys-OH·HCl day in and day out opens your eyes to what really matters in an amino acid raw material. This isn’t one of those commodity bulk items churned out with a cookie-cutter approach. Each batch, you see the importance of purity, consistency, and precise handling—because in peptide synthesis, every little detail finds its way into the final product. Our H-Lys-OH·HCl is designed for labs looking to cut out variables at the earliest stage. Experience has taught us that even a minor deviation—extra moisture, trace metal contamination, inconsistent particle size—leaves consequences that no purification step fully corrects. That's why all our energy goes into nailing those specs, every single run, over years of producing this essential building block.

    Not All Lysine Hydrochloride Is Created Equal

    Over time, we've fielded questions about using generic lysine monohydrochloride in place of specialty forms. For simple feed or food applications, the distinction sometimes doesn't seem to matter—until you step into organic synthesis. The catch most buyers miss involves isomer content, optical activity, and the subtle role of enantiomeric purity. Our product specifically provides the L-isomer, H-Lys-OH·HCl, designed for peptide conjugation and pharmaceutical intermediate development. The generic stuff? Often a racemate or contains significant D-isomer that can derail bioactivity or introduce immunogenicity further downstream. Chemical manufacturing isn’t just about what’s on the label—it's about the process controls and certifications standing behind that label, especially with something as fundamental as lysine.

    Why H-Lys-OH·HCl Demands This Attention

    Watch a pharma client run a costly peptide synthesis, only to discover substandard lysine triggering incomplete couplings or unwanted side reactions. These aren't just academic problems—they cost time, money, and can even lead to regulatory questions over the source of problems in final QC. The headaches come not from dramatic failures but from subtle performance drops batch-to-batch. This is why we maintain strict process validation, including advanced chiral HPLC, to guard consistency. One actual case we supported involved a customer whose finished peptide displayed inconsistent binding to a target protein. Root cause analysis traced the variability back to inconsistent L/D ratios in starter lysine. With a reliable H-Lys-OH·HCl source, their synthesis stabilized, yield went up, and costly troubleshooting disappeared from the agenda. Experience like this shapes the way we handle absolutely every kilogram we turn out.

    Specifications and Practicalities That Matter to the Chemist

    If you could stand next to our production line, the sights and sounds—reactors humming, vacuum lines adjusting pressure, close attention to crystallization curves—make it clear this is no afterthought process. Our H-Lys-OH·HCl comes in a fine, white crystalline form, with typical batch purities exceeding 99%. We've standardized on water contents below 0.5% by Karl Fischer, and every lot beats tight limits for heavy metals, thanks to upstream deionization and scrupulous cleaning between lots. The hydrochloride salt is carefully titrated to maintain homogeneity. If you've ever struggled with static, caking, or slow dissolution, you'd notice ours flows easier, dissolves rapidly in water, and doesn't turn yellow after storage. That reliability isn’t magic—it’s consistent use of pharmaceutical-grade reagents and a fixation on full solvent removal by lyophilization, not just oven heat.

    It's not only what we put in, but equally what we leave out. Take endotoxin contamination: many lysine sources are fine for feed use but fail to prevent lipopolysaccharide carryover. Our customers in peptide vaccine and injectable drug development specifically ask about endotoxin levels. This means validated cleaning, filtered air systems, and continuous monitoring throughout each batch. Not every factory can—or wants to—meet those requirements. We do, because the real world tells us failures aren’t just theoretical.

    How Manufacturing Expertise Makes the Difference

    Having spent decades with reactors and cleanrooms, our production teams spot problems no spec sheet alone would reveal. That’s how we learned to anticipate challenges like particle size control—too coarse, and solid-phase peptide reactions fail; too fine, and you get dust, clogs, or inconsistent weighing. Our blending and packaging lines get regular upgrades for that reason. Real chemical manufacturing, as opposed to trading or brokerage, means you own every outcome from raw ingredient selection through to final packing. It’s a level of care that makes downstream synthesis easier, less wasteful, and more robust.

    We've also learned that documentation helps make or break a supplier relationship. Regulatory agencies, especially when dealing with APIs and GMP intermediates, scrutinize every certificate and production record. Our batches come with full traceability right back to raw materials, with all process data logged and archived. This satisfies both regulatory audit trails and the needs of researchers troubleshooting issues. You can trace a specific lot from fermentation substrate right down the chain through separation, purification, and drying.

    Key Differences from Commodity Lysine

    Too often, customers are burned by sourcing “high-purity” lysine from the open market, later finding that both origin and supply chain are murky. Direct manufacturing changes the conversation. Our lysine hydrochloride is not an animal-feed side product—nor is it optimized for bulk price at the expense of reproducibility. From source microorganism selection, through precise fermentation, to high-resolution separation, every step is built for pharmaceutical or research customers. We're not tweaking a commodity—it’s a dedicated, purpose-built chemical.

    One overlooked distinction involves the handling of potential cross-contaminants. We've seen sources that share reactors with products for agriculture or adhesives, leading to subtle but real risk of cross-transfer. Our facility houses only cGMP-compliant pharmaceutical chemicals. No chance of surface residue jumping lines or high-pH carryover affecting optical rotation. Customers get exactly what they expect, every lot.

    The User’s Experience: Cleaner, Smoother Synthesis

    Bringing our product into a customer’s workflow often means fewer headaches. Feedback over the years points to certain themes: more complete peptide chains, cleaner mass spectra, and better yields in coupling reactions when switching to our H-Lys-OH·HCl. One chemist shared that with a competitor’s product, side reactions increased, which they eventually attributed to minute levels of amine-reactive impurities—trace aldehydes from poor drying controls, for example. Our controlled evaporative drying prevents this. Another client, scaling up from milligrams to kilograms, relied on consistent solubility and buffering thanks to our strict salt-form control.

    Researchers with experience in peptide conjugates, and advanced diagnostics, often tell us the right raw lysine saves hours of frustrating troubleshooting. They see it in improved chromatographic separation and more predictable downstream coupling, which reduces the number of purification steps. Every day, keeping the building blocks free of unpredictable contaminants translates into less time worrying about double-checking for ghosts in the analytic spectra.

    Industry Trends and Customer Demands

    Looking at the last decade, demand for highly pure amino acid salts like H-Lys-OH·HCl has only increased. Pharmaceutical innovation—biosimilars, peptide-based medicines, and advanced diagnostics—all place higher demands on raw materials. No longer is it enough to claim a “USP” purity if it comes with batch-to-batch surprises. End-users want robust supply agreements, reproducible results, and full transparency. We respond by running parallel lots, keeping redundant documentation, and investing heavily in analytical technology. The labs that receive our product want to push development at scale, not spend costly hours fixing problems that started at the supplier’s facility.

    The market only gets more sophisticated. Trace metals—once an afterthought—now mean the difference between regulatory approval and weeks of requalification. We exceed even the most strict requirements by rejecting lots at the earliest hint of nickel, copper, or iron outside ultra-trace levels, thanks to in-line ICP-MS testing. The expectations for amino acid building blocks fall squarely on the supplier, not just in purity but also in reliability, and we stand behind every unit out the door.

    H-Lys-OH·HCl and Compliance With International Standards

    Seeing regulatory requirements ratchet upward in both the EU and North America, we've prioritized batch certification, ISO documentation, and robust shipping validation for our H-Lys-OH·HCl. We know that customers are audited on incoming materials, right down to shipping and storage. Our shipments carry not just batch records, but also validated stability data. Stability, both in finished goods and in transit, becomes a lifecycle consideration—not simply a box checked at batch release. Factory control, not just paperwork, supports that.

    Because our customers include companies with strict compliance checks, we maintain drug master files and provide access to technical data packages. Regulatory inspectors look for evidence that each lot matches its certificate, not just by number but in analytical trace and unique identifiers. Knowing how batches can drift, regular reference standards get updated and checked, and process parameters are kept within locked ranges. This isn’t just about satisfying auditors—it directly impacts product reliability for every client’s formulation and R&D efforts.

    Continuous Improvement and User Feedback

    The market doesn't stand still, and neither do we. After years on the production floor, it's clear that user feedback drives improvement as much as any internal audit. A regular stream of comments—from solubility preferences to packaging tweaks—have shaped our current process. Some groups, focused on high-throughput peptide synthesis, asked for enhanced flow and anti-caking performance. This led us to tweak drying protocols and invest in new packaging lines. Customers benefit directly, saving labor and reducing weighing errors thanks to free-flowing, stable bottles.

    We’ve even adjusted our process to answer new analytical questions about secondary contaminants, from rare earths to volatile organics. Chemists in the field spot issues no management system would ever notice—slightly off pH readings in dissolution, for example, or rare occurrences of static buildup. Those insights feed back into process design, with new antistatic liners and improved nitrogen flushing in packaging rooms. Each improvement is documented, retested, and rolled out only after multiple production cycles have validated stability and process impact.

    Challenges and Solutions in Manufacturing H-Lys-OH·HCl

    Producing H-Lys-OH·HCl brings challenges that only become apparent through hands-on production—a day in which a temperature excursion or trace-level contaminant can throw an entire batch off spec. We solve these issues through a combination of expert operators, robust control systems, and, above all, relentless batch testing. One simple lesson: never rush the recrystallization. Rushing results in unwanted polymorphs and sticky solids that won’t dissolve cleanly. We designed our plant around the slow, controlled cooling peaks that guarantee proper crystal growth every time.

    Shipping H-Lys-OH·HCl during humid seasons introduced caking issues in the past. Installing low-dew-point airlocks and including molecular sieve packets in every package dramatically reduced complaints. International customers run into customs delays, which is why we engineered our packaging to minimize the risk of spoilage during unforeseen holds by using high-barrier, multilayer plastics and vacuum-sealing wherever possible.

    On the analytical side, we continue to invest in new methods, such as expanded coverage for chiral degradation and impurity fingerprinting. That means not just looking for known contaminants, but remaining vigilant for changes—minor drifts in color or trace residue alert us to process changes far before a major issue appears. It's these laboratory routines, often repeated many times per week, that keep each lot true to the standards promised at order.

    Application Versatility: What Our Customers Are Really Doing

    Talking to clients, it’s clear that H-Lys-OH·HCl goes into a range of high-impact fields. Peptide synthesis probably dominates use cases—solid-phase, solution-phase, and even automated platforms. Formulators building up sequence-specific molecules need absolute assurance that each piece fits the next, or else they face cascading functional losses. H-Lys-OH·HCl is essential there.

    Diagnostic developers take advantage of its reactivity for conjugation, from immunoassay calibration standards to linker construction for antibody drug conjugates. The fine particle size, high solubility, and batch-to-batch uniformity let them scale results from milligrams in R&D up to multi-gram process batches with minimal recalibration. Some biotechnologists reach out for injectable-grade projects—purity and low endotoxins take center stage in their requests, and our investment in environmental and process control keeps their projects on track.

    A handful of customers develop specialty coatings and surface chemistry applications, looking for the right balance of amino reactivity and salt stability. For these projects, handling matters as much as chemical content, and our team works with users to ensure compatibility with their protocols. The flexibility to adapt to shifting requirements, informed by years of production experience and feedback, positions our H-Lys-OH·HCl as a trusted workhorse in programs from new drug delivery innovation to research-scale synthesis.

    Why Direct Manufacturing Creates Real Value

    Direct-from-factory supply isn’t just a slogan—it underpins everything our partners rely on, from detailed documentation and regulatory confidence down to practical delivery and packaging flexibility. Brokers and traders live on price fluctuations and distant inventories. Only vertically integrated manufacturers own every step—raw fermentation inputs, purification tech, storage logistics, and quality release. Our regular audits and open-door policy for customers illustrate our transparency. You know you’re getting not just a drum of lysine HCl, but the entire record of how and where it was made, with no blind spots or answer-dodging.

    In short, decades of experience meeting sometimes tough, always evolving requirements means that our H-Lys-OH·HCl goes beyond “high purity.” We know what’s at stake, and every run reflects the lessons learned on the production floor, in the lab, and from the world’s strictest regulatory environments. Working directly with manufacturers means you get answers to technical questions quickly, reliable shipment schedules, and a product track record that stands up to scrutiny. We remain committed to delivering H-Lys-OH·HCl that chemists and process engineers reach for first—because after years in the field, the details are what make every difference.